We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergy Therapeutics Plc | LSE:AGY | London | Ordinary Share | GB00B02LCQ05 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.245 | 8.52% | 3.12 | 2.95 | 3.20 | 3.075 | 2.875 | 2.88 | 2,801,938 | 16:35:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 59.59M | -43.07M | -0.0090 | -3.41 | 146.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/2/2020 17:31 | May be their adjuvant technology is being sort after for certain vaccine development programs? | audigger | |
12/2/2020 14:34 | Possibly an approach? | jpuff | |
12/2/2020 14:18 | Yeh massive trades late yesterday and high trade today someone must know something! | richsawko | |
12/2/2020 14:01 | Hello hello, is it Spring already? Are we coming out of hibernation? | jimmyloser | |
07/2/2020 07:25 | Privately I was hoping that news of a large and credible distribution partnership in mainland China (as alluded to) would be announced at results in March and that the news would add impetus to the bombed out share price. Did I say mainland China? I think that someone must have smashed the mirror in the Worthing board room! | jimmyloser | |
01/2/2020 19:40 | Interesting. However, still some way to go. | farmergeorge | |
01/2/2020 19:12 | First peanut allergy drug approved in USA. BBC online today.https://www.bb | jpuff | |
31/1/2020 08:15 | I'm prepared to wait. It would be crazy to sell out at this juncture imo | jpuff | |
29/1/2020 20:49 | Thanks for this. Well, this is very encouraging news. However, it will take several years before this finally becomes a marketable product, if indeed it ever does. I see that this was released at 12:00 GMT, but it had no impact on today's trading price. Indeed, sells exceed buys! Also, how far in advance are knowledgable investors in pharmaceuticals prepared to bet on this? | farmergeorge | |
28/1/2020 16:15 | Thanks timbo003, interesting. | farmergeorge | |
28/1/2020 15:45 | Worth watching | timbo003 | |
16/1/2020 17:20 | Equally bemused by this depressed share price, but holding tight myself as I'm sure we'll get going up again soon. | jpuff | |
16/1/2020 14:08 | Cash position is very strong and underpins the company. Slightly bemused at the share price as it does not reflect the business propsects | catch007 | |
16/1/2020 08:31 | It appears that we are considered something akin to a pariah stock these days, even the word peanut doesn't generate any excitement. Alas. impo | jimmyloser | |
16/1/2020 08:23 | Decided to get back in.But not 'bigly'. | hiraniha | |
16/1/2020 07:45 | All looks solid. Would be good if the dialogue with the regulatory authorities would lead to a path forward for the failed trail. I doubt a conclusion could be drawn on the existing data but if there was agreement as to what further testing may be needed this would be a step forward. | audigger | |
16/1/2020 07:31 | What a bargain our new Chinese investors appear to have picked up on the cheap. Providing that lessons really have been learned this could be pivotal for them. March 4th certainly looks like a good news day to me if that taster this morning was anything to go by. Good Luck AGY. impo/dyor | jimmyloser | |
09/1/2020 13:29 | Well let's stay optimistic (holders that is), as news can come or bids and there's plenty of stocks in this beaten down position at present! | jpuff | |
07/1/2020 19:52 | Seriously undervalued? You're joking. Three months on its hardly moved! | khoustello | |
07/1/2020 14:40 | Same here mate. | jpuff | |
07/1/2020 14:36 | Jpuff I agree, been waiting a long long time to make a profit on this. Still some way to go for me though | richsawko |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions